Department of Global Health and Development, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK.
Health Policy Plan. 2012 May;27 Suppl 2:ii62-76. doi: 10.1093/heapol/czr049. Epub 2011 Jul 6.
In recent years numerous new vaccines have been developed, offering potential reductions in the morbidity and mortality caused by a range of diseases. This has led to increased interest in decision-making about the adoption of new vaccines into national immunization programmes. This paper aims to systematically review the literature on national decision-making around the adoption of new vaccines. A thematic framework was developed inductively through analysis of the vaccine adoption decision-making frameworks included in the review. This thematic framework was then applied to the remaining studies included in the review. In total, 85 articles were included in the review: 39 articles describing examples of vaccine adoption decision-making, 26 presenting vaccine decision-making frameworks, 21 empirical articles of decision-making relating to vaccine adoption and 19 theoretical essays. An analysis of vaccine adoption decision-making frameworks identified nine broad categories of criteria: the importance of the health problem; vaccine characteristics; immunization programme considerations; acceptability; accessibility, equity and ethics; financial/economic issues; impact; alternative interventions and the decision-making process. The quality of the empirical studies was varied. Although some of the issues included in the frameworks were similar to those considered in the studies, there were also some notable differences. On the whole, the frameworks were more comprehensive than the studies, including a greater range of criteria. The existing literature provides a good foundation for further research into vaccine adoption decision-making. The current review, in pulling together what is already known and by identifying strengths, weaknesses and gaps in the existing evidence base, aims to encourage a more focused and rigorous approach to the topic in future. This could help to identify the most appropriate ways to develop vaccine adoption decision-making, so as to improve decisions and, ultimately, health outcomes.
近年来,开发了许多新疫苗,为降低一系列疾病的发病率和死亡率提供了可能。这导致人们对采用新疫苗纳入国家免疫规划的决策产生了更大的兴趣。本文旨在系统地回顾有关采用新疫苗的国家决策的文献。通过分析综述中包含的疫苗采用决策框架,采用归纳法制定了一个主题框架。然后将该主题框架应用于综述中包含的其余研究。总共纳入了 85 篇文章:39 篇描述疫苗采用决策的例子,26 篇介绍疫苗决策框架,21 篇关于疫苗采用的决策的实证文章和 19 篇理论论文。对疫苗采用决策框架的分析确定了九个广泛的标准类别:健康问题的重要性;疫苗特性;免疫规划考虑因素;可接受性;可及性、公平性和道德;财务/经济问题;影响;替代干预措施和决策过程。实证研究的质量各不相同。虽然框架中包含的一些问题与研究中考虑的问题相似,但也存在一些明显的差异。总的来说,框架比研究更全面,包括更多种类的标准。现有文献为进一步研究疫苗采用决策提供了良好的基础。本综述通过总结已知内容并确定现有证据基础的优势、劣势和差距,旨在鼓励未来更有针对性和更严格地研究这一主题。这有助于确定制定疫苗采用决策的最合适方法,从而改善决策并最终改善健康结果。